Methylenedioxypyrovalerone (MDPV) is a stimulant of the cathinone class which acts as a Norepinephrine–dopamine reuptake inhibitor (NDRI).. It was first developed in the 1960s by a team at Boehringer Ingelheim.. Its activity at the dopamine transporter is six times stronger than at the norepinephrine transporter and it is virtually inactive at the serotonin transporter.. MDPV remained an obscure stimulant until around 2004 when it was reportedly sold as a designer drug.
|Oral, insufflation, intravenous, rectal, vaporization|
|Excretion||Primarily urine (renal)|
|Chemical and physical data|
|Molar mass||275.343 g/mol (freebase) g·mol−1|
|3D model (JSmol)|